Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Becomes FDA Commissioner With Immediate Issues Pending

May 11 2017

• By Derrick Gingery and Ryan Nelson

Related Content

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Jan 31 2017

Ostroff: Administration Coming Up To Speed On Planned FDA Guidances

May 05 2017

FDA Gains Budget Increase In FY 2017 … And Not Through Fees

May 02 2017

Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post

Jan 10 2017

Cosmetics Provisions Unlikely To Catch Ride On FDA User-Fee Bill

Apr 27 2017

Gottlieb Recognizes OTC Monograph Woes During Confirmation Hearing

Apr 06 2017

Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?

Nov 05 2016

Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?

Mar 22 2017

Additional Topics

United States FDA Regulation Cosmetics Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window